OSCR

In silico receptor binding and ex vivo nasal epithelial membrane permeation studies of selected phytocannabinoids.

Overview

Authors: Suzanne E. Van Niekerk1, Theunis Cloete1, Frank Van der Kooy1, Josias H. Hamman1
  1. Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), North-West University,Private Bag X6001, Potchefstroom, 2520 South Africa
Institutions: North-West University (South Africa)
Journal: Journal of cannabis research, volume 8, issue 1, article 56
Dates: received 10 October 2024; accepted 12 November 2025; published online 16 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s42238-025-00363-y · PMID 41992383 · PMCID PMC13104410 · OpenAlex W7154629410
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: computational modeling (no new data) (modality), pain (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Migraine, Cannabis sativa, Cannabinoid receptor type 2, Receptor docking, Computer-aided drug design, Ex vivo permeation, Intranasal drug delivery
Topic: Cannabis and Cannabinoid Research (Pharmacology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 66 references in the paper

Abstract

Background: Headache disorders, specifically migraine headaches, are highly debilitating neurological disorders, with the potential to incapacitate an individual for several hours. Cannabinoid receptors are present in both peripheral and central nervous tissue, which serve as a potential target for the treatment of migraine. Cannabis sativa is a medicinal plant that has been used as self-medication for the treatment of headaches, but insufficient scientific information is currently available regarding their interactions with receptors, as well as intranasal delivery. The intranasal route of administration offers the potential for systemic delivery, as well as delivery into the brain. Nose-to-brain delivery offers a pathway directly to the brain via olfactory epithelium and trigeminal nerves and bypasses both the first-pass metabolism and the blood-brain-barrier (BBB).

Methods: Known phytochemicals of C. sativa were docked in silico into the active site of the 6KPC crystal structure of the cannabinoid type 2 (CB2) receptor to screen for receptor affinity. Ex vivo permeation studies were done on these four selected cannabinoid compounds across excised sheep nasal epithelial tissue.

Results: Four cannabinoid compounds were identified with affinity for the CB2 receptor that may provide activity against migraine, namely cannabicyclol, cannabidiolic acid, cannabicitran and cannabielsoin. The ex vivo membrane permeation results revealed that some of the cannabinoids can be delivered to a similar extent than moderately permeable model drugs across nasal epithelium for systemic delivery and potentially also for direct nose-to-brain delivery.

Conclusion: Through affinity for the CB2 receptor, the identified compounds have shown potential in migraine treatment. There is also potential for nose-to-brain delivery.

Supplementary Information: The online version contains supplementary material available at 10.1186/s42238-025-00363-y.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

Data is provided within the manuscript or supplementary information files.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 7 keywords, 64 references.

Cite

This paper

Van Niekerk, S. E., Cloete, T., Van der Kooy, F., & Hamman, J. H. (2026). In silico receptor binding and ex vivo nasal epithelial membrane permeation studies of selected phytocannabinoids. Journal of cannabis research, 8(1), 56. https://doi.org/10.1186/s42238-025-00363-y

BibTeX

@article{vanniekerk2026silico,
author = {Van Niekerk, Suzanne E. and Cloete, Theunis and Van der Kooy, Frank and Hamman, Josias H.},
title = {{In silico receptor binding and ex vivo nasal epithelial membrane permeation studies of selected phytocannabinoids}},
journal = {Journal of cannabis research},
year = {2026},
month = apr,
volume = {8},
number = {1},
pages = {56},
publisher = {BMC},
issn = {2522-5782},
doi = {10.1186/s42238-025-00363-y},
url = {https://doi.org/10.1186/s42238-025-00363-y},
pmid = {41992383},
pmcid = {PMC13104410}
}

RIS

TY - JOUR
AU - Van Niekerk, Suzanne E.
AU - Cloete, Theunis
AU - Van der Kooy, Frank
AU - Hamman, Josias H.
TI - In silico receptor binding and ex vivo nasal epithelial membrane permeation studies of selected phytocannabinoids
T2 - Journal of cannabis research
J2 - J Cannabis Res
PY - 2026
DA - 2026/04/16
VL - 8
IS - 1
SP - 56
SN - 2522-5782
PB - BMC
DO - 10.1186/s42238-025-00363-y
UR - https://doi.org/10.1186/s42238-025-00363-y
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s42238-025-00363-y",
"type": "article-journal",
"title": "In silico receptor binding and ex vivo nasal epithelial membrane permeation studies of selected phytocannabinoids",
"container-title": "Journal of cannabis research",
"author": [
{
"family": "Van Niekerk",
"given": "Suzanne E."
},
{
"family": "Cloete",
"given": "Theunis"
},
{
"family": "Van der Kooy",
"given": "Frank"
},
{
"family": "Hamman",
"given": "Josias H."
}
],
"container-title-short": "J Cannabis Res",
"volume": "8",
"issue": "1",
"page": "56",
"DOI": "10.1186/s42238-025-00363-y",
"PMID": "41992383",
"PMCID": "PMC13104410",
"ISSN": "2522-5782",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s42238-025-00363-y",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
16
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/cimb48040369
Elucidating the Multi-Target Anti-Pruritic Mechanism of <i>Polygonatum odoratum</i> via Integrated Network Pharmacology, Molecular Simulations, and GEO Dataset Validation.
Journal: Current issues in molecular biology
In common: computational modeling (no new data), cellular / molecular, 1 reference
[2] doi:10.1038/s41467-026-75444-4 [code]
Structural insights enable drug discovery for the neuronal NBCn2 carbonate transporter.
Journal: Nature communications
In common: cellular / molecular, 1 reference
[3] doi:10.1016/j.omtn.2026.103028
Intranasal Tat-modified PEG-PCL nanomicelles delivering anti-RelA siRNA attenuate ischemia-reperfusion injury.
Journal: Molecular therapy. Nucleic acids
In common: cellular / molecular, 1 reference
[4] doi:10.1096/fj.202601712r
Time- and Region-Specific Effects of Intranasal Insulin on Oxidative Stress Parameters in the Rat Brain.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
In common: cellular / molecular, 1 reference
[5] doi:10.1073/pnas.2609132123 [code]
A human lysosomal storage disorder toolkit for decoding proteome landscapes in cortical-like and dopaminergic-like induced neurons.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: cellular / molecular, 1 reference
[6] doi:10.3390/ijms27135902
Functional Expression of Nicotinic Receptors on iPSC-Derived Astrocytes and Signalling Disturbances by a Panel of Neonicotinoid Pesticides and Their Metabolites.
Journal: International journal of molecular sciences
In common: cellular / molecular, 1 reference
[7] doi:10.1021/acschemneuro.5c00873
Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models.
Journal: ACS chemical neuroscience
In common: cellular / molecular, 1 reference
[8] doi:10.3390/metabo16080541
Spatial Metabolomics and Single-Cell Virtual Knockout Screening Reveal Solanesol Improves Parkinson's Disease-like Pathology Based on Lipid Inflammation Mechanism.
Journal: Metabolites
In common: cellular / molecular, 1 reference
[9] doi:10.3390/ijms27146196
Investigation of the Potential Neuroprotective Mechanisms of <i>Acalypha indica</i> Against Alzheimer's Disease by Integrated Bioinformatics Analysis.
Journal: International journal of molecular sciences
In common: cellular / molecular, 1 reference
[10] doi:10.1038/s41467-026-71574-x
CB1 receptor signaling at the cingulate-striatal circuit is anxiogenic.
Journal: Nature communications
In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.